SEC Form 4 · accession 0001171843-19-001389
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raymond J Land
Director
Period of report
Feb 26, 2019
Accepted (ET)
Feb 28, 2019 · 4:34 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 26, 2019 | A | 3,842 | $0.00 | A | 18,992 | D | |
| Common StockF2 | Feb 26, 2019 | S | 4,000 | $33.06 | D | 14,992 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on February 26, 2020.
- F2On February 26, 2019, Mr. Land sold 4,000 shares in multiple trades ranging from $32.76 to $33.13. The price reported above reflects the weighted average sales price. Mr. Land undertakes to provide the Securities and Exchange Commission staff, the issuer, or any security holder, upon request, full information regarding the number of shares and prices at which the transactions were effected.